Cargando…

CDiP technology for reverse engineering of sporadic Alzheimer’s disease

Alzheimer’s disease (AD) is a neurodegenerative disease that causes cognitive impairment for which neither treatable nor preventable approaches have been confirmed. Although genetic factors are considered to contribute to sporadic AD, for the majority of AD patients, the exact causes of AD aren’t fu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kondo, Takayuki, Yada, Yuichiro, Ikeuchi, Takeshi, Inoue, Haruhisa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Nature Singapore 2022
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9968655/ https://www.ncbi.nlm.nih.gov/pubmed/35680997 http://dx.doi.org/10.1038/s10038-022-01047-8

Ejemplares similares

Role of ELK1 in regulating colorectal cancer progression: miR-31-5p/CDIP1 axis in CRC pathogenesis
por: Yan, Guoqiang, et al.
Publicado: (2023)

Metabolites of soil microorganisms modulate amyloid β production in Alzheimer’s neurons
por: Kondo, Takayuki, et al.
Publicado: (2022)

The Novel ALG-2 Target Protein CDIP1 Promotes Cell Death by Interacting with ESCRT-I and VAPA/B
por: Inukai, Ryuta, et al.
Publicado: (2021)

Coordinated increase of γ-secretase reaction products in the plasma of some female Japanese sporadic Alzheimer's disease patients: quantitative analysis of p3-Alcα with a new ELISA system
por: Konno, Tomoko, et al.
Publicado: (2011)

IL-33 Promotes the Growth of Non-Small Cell Lung Cancer Cells Through Regulating miR-128-3p/CDIP1 Signalling Pathway
por: Zhou, Xiaorong, et al.
Publicado: (2021)

MedCDI: A technology-based documentation and quality improvement initiative in neurosurgery
por: Porwal, Mokshal H., et al.
Publicado: (2022)

Burden of Clostridioides difficile infection (CDI) - a systematic review of the epidemiology of primary and recurrent CDI
por: Finn, Elaine, et al.
Publicado: (2021)

One-step induction of photoreceptor-like cells from human iPSCs by delivering transcription factors
por: Otsuka, Yuki, et al.
Publicado: (2022)

IL-33 Promotes the Growth of Non-Small Cell Lung Cancer Cells Through Regulating miR-128-3p/CDIP1 Signalling Pathway [Corrigendum]
Publicado: (2021)

IL-33 Promotes the Growth of Non-Small Cell Lung Cancer Cells Through Regulating miR-128-3p/CDIP1 Signalling Pathway [Retraction]
Publicado: (2023)

The Cervical Dystonia Impact Profile (CDIP-58): Can a Rasch developed patient reported outcome measure satisfy traditional psychometric criteria?
por: Cano, Stefan J, et al.
Publicado: (2008)

Induction of inverted morphology in brain organoids by vertical-mixing bioreactors
por: Suong, Dang Ngoc Anh, et al.
Publicado: (2021)

Doctor, my patient has CDI and should continue to receive antibiotics. The (unresolved) risk of recurrent CDI
por: Castro, Iván, et al.
Publicado: (2019)

A point-prevalence study on community and inpatient Clostridioides difficile infections (CDI): results from Combatting Bacterial Resistance in Europe CDI (COMBACTE-CDI), July to November 2018
por: Viprey, Virginie F, et al.
Publicado: (2022)

JBoss Weld CDI for Java platform
por: Finnegan, Ken
Publicado: (2013)

Focusing stewardship to help tackle CDI
Publicado: (2020)

SMT19969 for Clostridium difficile infection (CDI): in vivo efficacy compared with fidaxomicin and vancomycin in the hamster model of CDI
por: Sattar, Abdul, et al.
Publicado: (2015)

684. Characteristics of Patients with Initial Clostridioides difficile Infection (CDI) That Are Associated With Increased Risk of Multiple CDI Recurrences
por: Guh, Alice, et al.
Publicado: (2023)

Modeling Neurological Disorders with Human Pluripotent Stem Cell-Derived Astrocytes
por: Suga, Mika, et al.
Publicado: (2019)

Cardiac telocytes inhibit cardiac microvascular endothelial cell apoptosis through exosomal miRNA-21-5p-targeted cdip1 silencing to improve angiogenesis following myocardial infarction
por: Liao, Zhaofu, et al.
Publicado: (2021)

Multiple γ-secretase product peptides are coordinately increased in concentration in the cerebrospinal fluid of a subpopulation of sporadic Alzheimer’s disease subjects
por: Hata, Saori, et al.
Publicado: (2012)

Use of Electronic Data to Identify Risk Factors Associated with Clostridium difficile Infection (CDI) and to Develop CDI Risk Scores
por: Aukes, Laurie, et al.
Publicado: (2017)

Bezlotoxumab (BEZ) for Prevention of Clostridium Difficile Infection (CDI) Recurrence (rCDI): Outcomes in Patients with Substantial Renal Impairment (SRI)
por: Golan, Yoav, et al.
Publicado: (2017)

Transcriptomic profiling of sporadic Alzheimer’s disease patients
por: Caldwell, Andrew B., et al.
Publicado: (2022)

Fidaxomicin Preserves the Intestinal Microbiome During and After Treatment of Clostridium difficile Infection (CDI) and Reduces Both Toxin Reexpression and Recurrence of CDI
por: Louie, Thomas J., et al.
Publicado: (2012)

1211. Response to Fecal Microbiota Transplant (FMT) in Refractory Clostridioides difficile Infection (CDI) is Modest Compared to Recurrent CDI in Hospitalized Patients
por: Shin, Jae Hyun, et al.
Publicado: (2020)

New advances in the treatment of Clostridium difficile infection (CDI)
por: Hedge, Dennis D, et al.
Publicado: (2008)

The burden of CDI in the United States: a multifactorial challenge
por: Feuerstadt, Paul, et al.
Publicado: (2023)

Risk factors for recurrent Clostridium difficile infection (CDI) hospitalization among hospitalized patients with an initial CDI episode: a retrospective cohort study
por: Zilberberg, Marya D, et al.
Publicado: (2014)

Bezlotoxumab (BEZ) for Prevention of Clostridium difficile Infection (CDI) Recurrence (rCDI): Distinguishing Relapse from Reinfection with Whole Genome Sequencing (WGS)
por: Dorr, Mary Beth, et al.
Publicado: (2017)

Clinical and cognitive characteristics of preclinical Alzheimer's disease in the Japanese Alzheimer's Disease Neuroimaging Initiative cohort
por: Ihara, Ryoko, et al.
Publicado: (2018)

A Unifying Hypothesis for Familial and Sporadic Alzheimer's Disease
por: Proctor, Carole J., et al.
Publicado: (2012)

Genetic Variants and Related Biomarkers in Sporadic Alzheimer’s Disease
por: Guerreiro, Rita, et al.
Publicado: (2014)

Slower Dynamics and Aged Mitochondria in Sporadic Alzheimer's Disease
por: Martín-Maestro, Patricia, et al.
Publicado: (2017)

Can mouse models mimic sporadic Alzheimer’s disease?
por: Foidl, Bettina M., et al.
Publicado: (2019)

Brain Amyloid in Sporadic Young Onset Alzheimer’s Disease
por: Panegyres, Peter K., et al.
Publicado: (2023)

Cerebral Small Vessel Disease in Sporadic and Familial Alzheimer Disease
por: Kalaria, Rajesh N., et al.
Publicado: (2021)

Genetics of Alzheimer’s disease: an East Asian perspective
por: Miyashita, Akinori, et al.
Publicado: (2022)

Clostridioides difficile infection (CDI) during the COVID-19 pandemic
por: Spigaglia, Patrizia
Publicado: (2022)

BIN1 Is Decreased in Sporadic but Not Familial Alzheimer’s Disease or in Aging
por: Glennon, Elizabeth B. C., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_fcb2clgm3n3em9aj5dqrspoapr